KRMD

NEW: We've expanded Stock Detail, Screener, and Maps with new data

Stock Detail, Screener:
3, 5, 10-Year Performance
EV/EBITDA, EV/Sales
Dividend Growth (1, 3, 5 Years)
EPS & Sales Growth (3 Years)

Maps:
All from Screener plus:
ROA, ROE, ROIC
Quick & Current Ratios
LT Debt and Debt to Equity Ratios
Gross, Operating, and Net Margins

Dollar change +0.04
Percentage change 1.09	%

Peers: TMO BDX ABT SYK BAX BSX ZBH CAH HOLX STE

| Held by: VTI IWM VXF IWO IWC GSSC RSSL UWM URTY DFAC

Scroll to Statements

Index	RUT	P/E	-	EPS (ttm)	-0.12	Insider Own	4.90%	Shs Outstand	46.14M	Perf Week	3.63%
Market Cap	171.19M	Forward P/E	-	EPS next Y	-0.01	Insider Trans	0.00%	Shs Float	43.88M	Perf Month	27.05%
Enterprise Value	166.18M	PEG	-	EPS next Q	-0.02	Inst Own	51.29%	Short Float	0.89%	Perf Quarter	62.72%
Income	-5.30M	P/S	4.88	EPS this Y	50.00%	Inst Trans	15.96%	Short Ratio	1.59	Perf Half Y	-4.50%
Sales	35.08M	P/B	10.47	EPS next Y	92.31%	ROA	-19.36%	Short Interest	0.39M	Perf YTD	-3.64%
Book/sh	0.35	P/C	19.59	EPS next 5Y	-	ROE	-29.87%	52W High	5.05 -26.53%	Perf Year	46.06%
Cash/sh	0.19	P/FCF	-	EPS past 3/5Y	-8.83% -	ROIC	-27.28%	52W Low	1.86 99.46%	Perf 3Y	46.64%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	12.72% 7.75%	Gross Margin	61.00%	Volatility	5.66% 6.62%	Perf 5Y	-58.69%
Dividend TTM	-	EV/Sales	4.74	EPS Y/Y TTM	60.28%	Oper. Margin	-16.33%	ATR (14)	0.20	Perf 10Y	827.50%
Dividend Ex-Date	-	Quick Ratio	2.02	Sales Y/Y TTM	19.65%	Profit Margin	-15.10%	RSI (14)	69.09	Recom	1.40
Dividend Gr. 3/5Y	- -	Current Ratio	2.44	EPS Q/Q	40.09%	SMA20	8.37%	Beta	0.47	Target Price	5.50
Payout	-	Debt/Eq	0.23	Sales Q/Q	17.53%	SMA50	19.94%	Rel Volume	0.33	Prev Close	3.67
Employees	80	LT Debt/Eq	0.19	Earnings	May 07 AMC	SMA200	14.27%	Avg Volume	244.60K	Price	3.71
IPO	Apr 05, 1994	Option/Short	Yes / Yes	EPS/Sales Surpr.	100.00% 8.75%	Trades		Volume	30,043	Change	1.09%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-14-25	Downgrade	Piper Sandler	Overweight → Neutral	$4.50
Jul-25-24	Resumed	B. Riley Securities	Buy	$4
Sep-07-23	Initiated	Lake Street	Buy	$4
Sep-07-23	Initiated	B. Riley Securities	Buy	$4.50
Nov-10-22	Upgrade	Piper Sandler	Neutral → Overweight	$3 → $3.50
Nov-10-22	Upgrade	Canaccord Genuity	Hold → Buy	$3 → $4
Jan-26-21	Downgrade	Piper Sandler	Overweight → Neutral	$9 → $4.50
Jan-26-21	Downgrade	Canaccord Genuity	Buy → Hold	$5
Aug-10-20	Initiated	H.C. Wainwright	Buy	$16
Jul-16-20	Initiated	Canaccord Genuity	Buy	$13
Jun-24-20	Initiated	Piper Sandler	Overweight	$12

Show Previous Ratings

Jul-07-25 04:05PM	KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer (Business Wire)
Jun-11-25 04:05PM	KORU Medical Systems to Join Russell 3000 and Russell 2000 Indexes (Business Wire)
May-08-25 03:32AM	KORU Medical Systems Inc (KRMD) Q1 2025 Earnings Call Highlights: Record Revenue and Strategic ... (GuruFocus.com) +20.96%
May-07-25 05:50PM	KORU Medical Systems Inc. (KRMD) Reports Q1 Loss, Tops Revenue Estimates (Zacks)
04:05PM	KORU Medical Systems Announces Record Q1 2025 Financial Results and Raises 2025 Revenue Guidance (Business Wire)
04:05PM	Loading…
Apr-16-25 04:05PM	KORU Medical Systems to Report First Quarter 2025 Financial Results on May 7, 2025 (Business Wire)
Mar-13-25 03:08AM	KORU Medical Systems Inc (KRMD) Q4 2024 Earnings Call Highlights: Record Revenues and Strategic ... (GuruFocus.com) -17.68%
Mar-12-25 04:05PM	KORU Medical Systems Announces Fourth Quarter and Full Year 2024 Financial Results With Record Revenues and Gross Profit; Issues Full Year 2025 Guidance (Business Wire) +5.47%
Feb-19-25 04:05PM	KORU Medical Systems to Report Fourth Quarter and Full Year 2024 Financial Results on March 12, 2025 (Business Wire)
Feb-14-25 01:01PM	Piper Sandler Downgrades Koru Medical, Citing Valuation Concerns (GuruFocus.com) -8.00%
Feb-06-25 04:05PM	KORU Medical Systems Announces Agreement for Next-Generation Subcutaneous Immunoglobulin Infusion System (Business Wire)
Jan-30-25 04:05PM	KORU Medical Systems Announces Phase III Clinical Trial Collaboration for a New Drug Indication in Nephrology (Business Wire)
Jan-14-25 04:06PM	KORU Medical Systems Reports Preliminary Fourth Quarter and Full Year 2024 Results; Achieves Record Full Year and Quarterly Revenues; Positive Cash Flow for the Fourth Quarter (Business Wire)
Nov-25-24 04:05PM	KORU Medical Systems to Participate in Piper Sandler's 36th Annual Healthcare Conference (Business Wire)
Nov-15-24 07:16AM	Koru Medical price target raised to $4 from $3 at Canaccord (TipRanks)
02:16AM	Loading…
Nov-14-24 02:16AM	KORU Medical Systems Inc (KRMD) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ... (GuruFocus.com)
Nov-13-24 04:05PM	KORU Medical Systems, Inc. Announces 2024 Q3 Financial Results, Third Consecutive Quarter of Double-Digit Growth; Raises Full Year 2024 Guidance (Business Wire) +7.74%
Nov-06-24 04:05PM	KORU Medical Systems to Participate in Upcoming Investor Conferences (Business Wire)
Oct-31-24 04:03PM	KORU Medical Systems Presents Data at Partnership Opportunities in Drug Delivery (PODD) Conference Demonstrating Nursing Preference for Use of KORU FreedomEdge Infusion System over Manual Syringe Administration for Subcutaneous Oncology Infusion (Business Wire) +11.03% -7.53%
Oct-23-24 04:05PM	KORU Medical Systems to Report Third Quarter 2024 Financial Results on November 13, 2024 (Business Wire)
Oct-09-24 05:19PM	KORU Medical Systems Inc (KRMD) Q2 2024 Earnings Call Highlights: Record Revenue Growth and ... (GuruFocus.com) +6.20%
Sep-05-24 07:00AM	KORU Medical Systems to Participate in the 8th Annual Lake Street Best Ideas Growth Conference (Business Wire)
Aug-07-24 04:05PM	KORU Medical Systems, Inc. Announces 2024 Q2 Financial Results, a Record Quarter With 22% Revenue Growth; Raises Full Year 2024 Guidance (Business Wire) +16.43%
Jul-25-24 04:05PM	KORU Medical Systems to Participate in the Canaccord Genuity 44th Annual Growth Conference (Business Wire)
Jul-24-24 04:05PM	KORU Medical Systems, Inc Announces Leadership Changes to Support Growth Agenda (Business Wire)
Jul-17-24 04:05PM	KORU Medical Systems to Report Second Quarter 2024 Financial Results on August 7, 2024 (Business Wire)
Jul-03-24 12:27PM	KORU Medical's (KRMD) FreedomEdge Gets Regulatory Nod in Japan (Zacks) +11.89%
Jul-02-24 07:00AM	KORU Medical Systems Receives Regulatory Clearance for FreedomEdge Infusion System in Japan (Business Wire)
Jun-05-24 09:00AM	Simplifying Subcutaneous Drug Administration: SCHOTT Pharma and KORU Medical Systems Announce Collaboration to Advance Large Volume Subcutaneous Infusion (Business Wire)
Jun-04-24 04:03PM	KORU Medical Systems Announces a New Feasibility Study with a Commercialized Oncology Biologic (Business Wire)
04:05PM	Loading…
May-14-24 04:05PM	KORU Medical Systems Signs Supply Agreement for a Phase III Clinical Trial for a Novel Endocrinological Biologic (Business Wire)
May-02-24 10:29AM	KORU Medical Systems, Inc. (NASDAQ:KRMD) Q1 2024 Earnings Call Transcript (Insider Monkey) +5.78%
03:39AM	KORU Medical Systems Inc (KRMD) Q1 2024 Earnings Call Transcript Highlights: Record Revenue and ... (GuruFocus.com)
May-01-24 06:06PM	KORU Medical Systems Inc (KRMD) Q1 2024 Earnings: Revenue Surpasses Estimates Amidst Challenges (GuruFocus.com)
04:05PM	KORU Medical Systems, Inc. Announces 2024 First Quarter Financial Results Delivering Double-Digit Revenue Growth (Business Wire)
Apr-17-24 07:00AM	KORU Medical Systems to Report First Quarter 2024 Financial Results on May 1, 2024 (Business Wire)
Apr-11-24 04:05PM	KORU Medical Systems Announces Successful Appeal in EU Notified Body Review (Business Wire) -6.73%
Mar-18-24 05:24PM	KORU Medical Systems to Present Data Demonstrating 97% Adherence on Its Freedom Infusion System for Large Volume Subcutaneous Administration at NHIA 2024 Conference (Business Wire) -5.45%
Mar-13-24 04:05PM	KORU Medical Systems, Inc. Announces 2023 Fourth Quarter, Full Year Financial Results, and 2024 Guidance (Business Wire)
Mar-12-24 08:22AM	KORU Medical (KRMD) Forms New Deal on Subcutaneous Infusion (Zacks)
Mar-11-24 04:05PM	KORU Medical Systems Announces a Feasibility Study to Enter Ambulatory Infusion Settings with a Commercialized Biologic (Business Wire)
Mar-06-24 07:00AM	KORU Medical Systems Signs a Clinical Supply Agreement for Phase 3 Trial with Leading Pharma Partner Using Custom Device for a Novel Subcutaneous Immunoglobulin (Business Wire) +5.39%
Feb-21-24 07:00AM	KORU Medical Systems to Report Fourth Quarter and Full Year 2023 Financial Results on March 13, 2024 (Business Wire)
Nov-29-23 07:00AM	KORU Medical Systems to Participate in Piper Sandlers 35th Annual Healthcare Conference (Business Wire)
Nov-28-23 08:00AM	KORU Medical Systems, Inc. to Host Investor Day on December 5, 2023 (Business Wire)
Nov-09-23 10:04AM	KORU Medical Systems, Inc. (NASDAQ:KRMD) Q3 2023 Earnings Call Transcript (Insider Monkey) -7.31%
Nov-08-23 06:11PM	KORU Medical Systems Inc (KRMD) Reports Q3 2023 Financial Results and Updates Full Year Outlook (GuruFocus.com) -5.19%
04:10PM	KORU Medical Systems, Inc. Announces Development Agreement for Next-generation Subcutaneous Immunoglobulin Infusion System (Business Wire)
04:08PM	KORU Medical Systems, Inc. Appoints Ken Miller as Chief Commercial Officer (Business Wire)
04:05PM	KORU Medical Systems, Inc. Announces 2023 Third Quarter Financial Results and Updates Full Year 2023 Outlook (Business Wire)
Nov-07-23 04:05PM	KORU Medical Systems, Inc. Receives FDA 510(k) Clearance for FREEDOM60 Infusion System With Hizentra 50 ML Prefilled Syringes (Business Wire)
Nov-02-23 04:05PM	KORU Medical Systems to Participate in Upcoming Investor Conferences (Business Wire)
Oct-25-23 04:05PM	KORU Medical Systems to Report Third Quarter Financial Results on November 8, 2023 (Business Wire)
Oct-05-23 07:05AM	KORU Medical Systems to Present Two Abstracts at the Immunoglobulin National Society 2023 National Conference (Business Wire)
Oct-04-23 04:05PM	KORU Medical Systems, Inc. Announces Appointment of Edward Wholihan to Its Board of Directors (Business Wire)
Sep-15-23 08:05AM	KORU Medical Systems to Participate in the Gilmartin Group Emerging Growth Company Showcase (Business Wire)
Aug-09-23 04:05PM	KORU Medical Systems, Inc. Announces 2023 Second Quarter Financial Results and Updates Full Year 2023 Outlook (Business Wire)
Aug-08-23 04:05PM	KORU Medical Systems to Participate in the Genuity 43rd Annual Growth Conference (Business Wire)
Aug-02-23 05:15PM	KORU Medical Systems, Inc. Announces Preliminary Second Quarter 2023 Revenues and Provides Business, Outlook and Executive Updates (Business Wire)
Jul-31-23 04:05PM	KORU Medical Systems to Report Second Quarter Financial Results on August 9, 2023 (Business Wire)
Jul-27-23 04:05PM	KORU Medical Systems Announces Novel Therapies Collaboration for Late-Stage Endocrinological Biologic (Business Wire)
Jul-10-23 07:01AM	KORU Medical Systems, Inc. Announces 510(K) Submission for Freedom60® Infusion System With Hizentra® 50 Ml Prefilled Syringes (Business Wire)
Jun-27-23 07:05AM	KORU Medical Systems, Inc. Names Andrew LaFrence as Chief Financial Officer (Business Wire)
May-09-23 03:15PM	KORU Medical Systems, Inc. (NASDAQ:KRMD) Q1 2023 Earnings Call Transcript (Insider Monkey)
May-04-23 04:01PM	KORU Medical Systems, Inc. Announces 2023 First Quarter Financial Results (Business Wire)
Apr-21-23 07:01AM	KORU Medical Systems to Report First Quarter Financial Results on May 4, 2023 (Business Wire)
Mar-08-23 04:01PM	KORU Medical Systems Announces 2022 Q4 and Full Year Financial Results, Accelerating to 19% Revenue Growth in 2022 (Business Wire) -10.50%
Feb-22-23 04:01PM	KORU Medical Systems to Report Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023 (Business Wire)
Jan-25-23 07:01AM	KORU Medical Systems Announces Subcutaneous Immunoglobulin Prefilled Syringe Development Agreement (Business Wire)
Nov-21-22 07:01AM	KORU Medical Systems to Participate in the Piper Sandler 34th Annual Healthcare Conference (Business Wire)
Nov-10-22 04:01PM	KORU Medical Systems to Participate in Upcoming Investor Conferences (Business Wire) +16.88% +10.00%
Nov-09-22 04:01PM	KORU Medical Systems Announces 2022 Third Quarter Financial Results (Business Wire)
Nov-08-22 07:01AM	KORU Medical Systems Announces Novel Therapy Collaboration for Three Indications with Kira Pharmaceuticals (Business Wire)
Oct-26-22 04:01PM	KORU Medical Systems to Report Third Quarter 2022 Financial Results on November 9, 2022 (Business Wire)
Oct-17-22 04:01PM	KORU Medical Systems to Participate in Upcoming Industry Conferences (Business Wire)
Oct-12-22 07:01AM	KORU Medical Systems Appoints Brent Rutland as Vice President of Medical Affairs (Business Wire)
Oct-05-22 07:01AM	KORU Medical Systems Joins Subcutaneous Drug Development & Delivery Consortium (Business Wire)
Aug-08-22 09:50AM	We're Not Very Worried About KORU Medical Systems' (NASDAQ:KRMD) Cash Burn Rate (Simply Wall St.)
Aug-03-22 04:01PM	KORU Medical Systems Announces 2022 Second Quarter Financial Results (Business Wire)
Jul-20-22 04:01PM	KORU Medical Systems to Report Second Quarter 2022 Financial Results on August 3, 2022 (Business Wire) +5.64%
Jul-05-22 07:08AM	Investors in Repro Med Systems (NASDAQ:KRMD) have made a fantastic return of 483% over the past five years (Simply Wall St.)
May-10-22 01:29PM	What You Need To Know About Repro Med Systems, Inc.'s (NASDAQ:KRMD) Investor Composition (Simply Wall St.)
May-04-22 04:01PM	KORU Medical Systems Announces 2022 First Quarter Financial Results (Business Wire) +6.87% -7.86%
May-02-22 04:01PM	KORU Medical Systems Receives FDA 510(k) Clearance for Delivery of EMPAVELI® (pegcetacoplan), Expands European Label for FreedomEdge® (Business Wire)
Apr-20-22 04:01PM	KORU Medical Systems to Report First Quarter 2022 Financial Results on May 4, 2022 (Business Wire) -6.90%
Apr-18-22 05:00PM	KORU Medical Systems Appoints Brian Case As Chief Technology Officer (Business Wire) +6.76%
Mar-28-22 04:47PM	Repro Med Systems, Inc. (NASDAQ:KRMD) drops to US$125m and insiders who purchased earlier this year lose another US$38k (Simply Wall St.)
Mar-02-22 04:01PM	KORU Medical Systems Announces 2021 Q4 and Full Year Financial Results (Business Wire) -5.05%
Feb-23-22 03:00PM	Analysts Estimate Repro Med Systems, Inc. (KRMD) to Report a Decline in Earnings: What to Look Out for (Zacks)
Feb-22-22 12:30AM	CORRECTING and REPLACING KORU Medical Systems to Report Fourth Quarter and Full Year 2021 Financial Results on March 2, 2022 (Business Wire)
Jan-26-22 07:02AM	Those who invested in Repro Med Systems (NASDAQ:KRMD) five years ago are up 523% (Simply Wall St.) +5.11%
Dec-21-21 04:01PM	KORU Medical Systems Receives FDA 510(k) Clearance for the Use of the FREEDOM60® with Two Additional SCIg Drugs (Business Wire)
Dec-01-21 04:01PM	KORU Medical Systems to Unveil Updated Strategic Plan at Investor Day (Business Wire) +9.28%
Nov-27-21 08:06AM	What You Need To Know About Repro Med Systems, Inc.'s (NASDAQ:KRMD) Investor Composition (Simply Wall St.)
Nov-10-21 04:00PM	KORU Medical Announces FDA Clearance for Delivery of Hizentra® Prefilled Syringes (Business Wire) +25.18%
Nov-09-21 07:00AM	KORU Medical Systems to Participate in Two Upcoming Conferences (Business Wire) -6.04%
Nov-08-21 07:00AM	KORU Medical Announces Collaboration With Gilero to Accelerate Innovation (Business Wire)
Nov-01-21 07:00AM	KORU Medical Expands Senior Team to Accelerate Growth Strategy (Business Wire) +13.25%
Oct-27-21 04:01PM	KORU Medical Systems to Report Third Quarter 2021 Financial Results on November 10, 2021 (Business Wire)
Oct-26-21 03:02PM	Earnings Preview: Repro Med Systems, Inc. (KRMD) Q3 Earnings Expected to Decline (Zacks)

KORU Medical Systems, Inc. engages in the design, manufacture, and market of proprietary medical devices. Its product portfolio includes FREEDOM60, FreedomEdge syringe drivers, Precision Flow Rate Tubing, and HIgH-Flo Subcutaneous Safety Needle Sets. The company was founded by Andrew I. Sealfon and Adrian W. Zorgniotti on March 24, 1980 and is headquartered in Mahwah, NJ.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Tharby Linda M	Officer	Apr 21 '25	Proposed Sale	2.20	23,587	51,955		Apr 21 05:15 PM
Tharby Linda M	Chief Executive Officer	Mar 17 '25	Option Exercise	0.00	15,968	0	1,085,411	Mar 21 04:35 PM
Miller Kenneth E	Chief Commercial Officer	Mar 17 '25	Option Exercise	0.00	5,893	0	5,893	Mar 21 04:32 PM
Adams Thomas Edward	Chief Financial Officer	Mar 17 '25	Option Exercise	0.00	5,404	0	5,404	Mar 21 04:30 PM
Pazdan Christopher	Officer	Mar 19 '25	Proposed Sale	2.84	14,490	41,157		Mar 19 04:40 PM
Tharby Linda M	Officer	Mar 19 '25	Proposed Sale	2.83	29,813	84,502		Mar 19 04:32 PM
Tharby Linda M	Officer	Mar 17 '25	Proposed Sale	2.89	8,848	25,547		Mar 17 04:51 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

KORU Medical Systems Inc

Upgrade your FINVIZ experience